Merck
MRK
#42
Rank
A$514.08 B
Marketcap
A$208.37
Share price
2.26%
Change (1 day)
54.17%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$2.04

According to Merck's latest financial reports the company's current EPS (TTM) is A$1.81. In 2025 the company made an earnings per share (EPS) of A$10.46 an increase over its 2024 EPS that were of A$9.67.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.04-80.47%
2025A$10.468.15%
2024A$9.674308.46%
2023A$0.22-97.32%
2022A$8.2010.92%
2021A$7.3984.68%
2020A$4.00-27.2%
2019A$5.5063.44%
2018A$3.36151.11%
2017A$1.34-54.58%
2016A$2.9530.21%
2015A$2.27-61.99%
2014A$5.96180.51%
2013A$2.12-31.82%
2012A$3.126.62%
2011A$2.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.50 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.53 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.09-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.46 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.77 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.21 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.72 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.50 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.58 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.90-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel